Hillary M Topazian - JoVE Visualize

Showing results (31-40 of 33) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 33 results.

Plos One|September 11, 2025

Prevalence of asymptomatic non-falciparum and falciparum malaria in the 2014-15 Rwanda Demographic Health SurveyClaudia Gaither, Camille Morgan, Rebecca Kirby, et al.

Frontiers in Epidemiology|March 8, 2024

Low Complexity of Infection Is Associated With Molecular Persistence of <i>Plasmodium falciparum</i> in Kenya and TanzaniaHillary M Topazian, Kara A Moser, Billy Ngasala, et al.

The Lancet. Infectious Diseases|February 11, 2024

The public health impact and cost-effectiveness of the R21/Matrix-M malaria vaccine: a mathematical modelling studyNora Schmit, Hillary M Topazian, H Magloire Natama, et al.

Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 33 results.

Plos One|September 11, 2025

Prevalence of asymptomatic non-falciparum and falciparum malaria in the 2014-15 Rwanda Demographic Health SurveyClaudia Gaither, Camille Morgan, Rebecca Kirby, et al.

Frontiers in Epidemiology|March 8, 2024

Low Complexity of Infection Is Associated With Molecular Persistence of <i>Plasmodium falciparum</i> in Kenya and TanzaniaHillary M Topazian, Kara A Moser, Billy Ngasala, et al.

The Lancet. Infectious Diseases|February 11, 2024

The public health impact and cost-effectiveness of the R21/Matrix-M malaria vaccine: a mathematical modelling studyNora Schmit, Hillary M Topazian, H Magloire Natama, et al.

Pageof 4